This past June, the U.S. Food and Drug Administration approved Aduhelm (aducanumab) for the treatment of Alzheimer’s disease via an Accelerated Approval pathway.
ACAD stands against anti-Asian hate. Please read through the following article for links to the ACAD statement and statements from the ACAD members’ institutions and projects.
ACAD releases a statement addressing the tragedy in Atlanta that occurred on March 16, 2021
Happy Lunar New Year! From the ACAD Study, we wish you all good health, good fortune, and a prosperous year of the Ox!
Forbes featured ACAD MPI Dr. Park in an article for her work using Korean dramas as a mental health education tool for Asian Americans.